Elixinol Wellness Limited
ELLXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $14,956 | $8,269 | $7,055 | $9,338 |
| % Growth | 80.9% | 17.2% | -24.4% | – |
| Cost of Goods Sold | $9,314 | $4,849 | $10,321 | $15,593 |
| Gross Profit | $5,642 | $3,420 | -$3,266 | -$6,255 |
| % Margin | 37.7% | 41.4% | -46.3% | -67% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5,483 | $6,167 | $4,444 | $12,954 |
| SG&A Expenses | $7,872 | $7,985 | $6,736 | $16,636 |
| Sales & Mktg Exp. | $2,389 | $1,818 | $2,292 | $3,682 |
| Other Operating Expenses | $2,876 | $1,897 | $0 | -$7,282 |
| Operating Expenses | $10,748 | $9,882 | $6,736 | $9,354 |
| Operating Income | -$5,106 | -$6,462 | -$10,002 | -$15,609 |
| % Margin | -34.1% | -78.1% | -141.8% | -167.2% |
| Other Income/Exp. Net | -$205 | -$1,042 | -$567 | -$1,481 |
| Pre-Tax Income | -$5,311 | -$7,504 | -$10,569 | -$17,090 |
| Tax Expense | -$3,589 | $3 | $2 | -$65 |
| Net Income | -$1,722 | -$7,507 | -$10,571 | -$17,025 |
| % Margin | -11.5% | -90.8% | -149.8% | -182.3% |
| EPS | -0.011 | -0.099 | -0.026 | -0.042 |
| % Growth | 88.8% | -280.4% | 38.2% | – |
| EPS Diluted | -0.011 | -0.099 | -0.026 | -0.042 |
| Weighted Avg Shares Out | 154,552 | 75,879 | 406,384 | 404,769 |
| Weighted Avg Shares Out Dil | 154,552 | 75,879 | 406,384 | 404,769 |
| Supplemental Information | – | – | – | – |
| Interest Income | $30 | $213 | $22 | $47 |
| Interest Expense | $177 | $101 | $71 | $92 |
| Depreciation & Amortization | $1,042 | $597 | $721 | $487 |
| EBITDA | -$4,092 | -$6,806 | -$9,281 | -$15,122 |
| % Margin | -27.4% | -82.3% | -131.6% | -161.9% |